1. Bressan, FF, De Bem, TH, Perecin, F, et al. Unearthing the roles of imprinted genes in the placenta. Placenta. 2009; 30, 823–834.
2. Charalambous, M, da Rocha, ST, Ferguson-Smith, AC. Genomic imprinting, growth control and the allocation of nutritional resources: consequences for postnatal life. Curr Opin Endocrinol Diabetes Obes. 2007; 14, 3–12.
3. Court, F, Tayama, C, Romanelli, V, et al. Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment. Genome Res. 2014; 24, 554–569.
4. Kappil, MA, Green, BB, Armstrong, DA, et al. Placental expression profile of imprinted genes impacts birth weight. Epigenetics. 2015; 10, 842–849.
5. Lambertini, L, Marsit, CJ, Sharma, P, et al. Imprinted gene expression in fetal growth and development. Placenta. 2012; 33, 480–486.
6. Wolpert, L, Tickle, C, Lawrence, P, et al. Principles of Development, 4th edn, 2010. Oxford University Press: New York, NY.
7. Hu, D, Cross, JC. Development and function of trophoblast giant cells in the rodent placenta. Int J Dev Biol. 2010; 54, 341–354.
8. Perry, JK, Lins, RJ, Lobie, PE, Mitchell, MD. Regulation of invasive growth: similar epigenetic mechanisms underpin tumour progression and implantation in human pregnancy. Clin Sci (Lond). 2010; 118, 451–457.
9. Schroeder, DI, Blair, JD, Lott, P, et al. The human placenta methylome. Proc Natl Acad Sci U S A. 2013; 110, 6037–6042.
10. Newman, JR, Ghaemmaghami, S, Ihmels, J, et al. Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise. Nature. 2006; 441, 840–846.
11. Zaitoun, I, Downs, KM, Rosa, GJ, Khatib, H. Upregulation of imprinted genes in mice: an insight into the intensity of gene expression and the evolution of genomic imprinting. Epigenetics. 2010; 5, 149–158.
12. Kaern, M, Elston, TC, Blake, WJ, Collins, JJ. Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet. 2005; 6, 451–464.
13. Sanchez, A, Choubey, S, Kondev, J. Regulation of noise in gene expression. Ann Rev Biophys. 2013; 42, 469–491.
14. Blake, WJ, Kaern, M, Cantor, CR, Collins, JJ. Noise in eukaryotic gene expression. Nature. 2003; 422, 633–637.
15. Fraser, HB, Hirsh, AE, Giaever, G, Kumm, J, Eisen, MB. Noise minimization in eukaryotic gene expression. PLoS Biol. 2004; 2, e137.
16. Ruiz, S, Lopez-Contreras, AJ, Gabut, M, et al. Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells. Nat Commun. 2015; 6, 8036.
17. Kappil, MA, Li, Q, Li, A, et al. In utero exposures to environmental organic pollutants disrupt epigenetic marks linked to fetoplacental development. Environ Epigenetics. 2016; 2, dvv013.
18. Chen, J, Li, Q, Rialdi, A, et al. Influences of maternal stress during pregnancy on the epi/genome: comparison of placenta and umbilical cord blood. J Depress Anxiety. 2014; 3, 1–6.
19. Grote, NK, Bridge, JA, Gavin, AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010; 67, 1012–1024.
20. Loomans, EM, van Dijk, AE, Vrijkotte, TG, et al. Psychosocial stress during pregnancy is related to adverse birth outcomes: results from a large multi-ethnic community-based birth cohort. Eur J Public Health. 2013; 23, 485–491.
21. O'Donnell, KJ, Meaney, MJ. Fetal origins of mental health: The developmental origins of health and disease hypothesis. Am J Psychiatry. 2017; 174, 319–328.
22. Finik, J, Nomura, Y. Cohort profile: stress in pregnancy (SIP) study. Int J Epidemiol. 2017; 46, 1388–1388k.
23. Zhang, W, Li, Q, Deyssenroth, M, et al. Timing of prenatal exposure to trauma and altered placental expressions of hypothalamic-pituitary-adrenal axis genes and genes driving neurodevelopment. J Neuroendocrinol. 2018; 30, e12581.
24. Green, BB, Kappil, M, Lambertini, L, et al. Expression of imprinted genes in placenta is associated with infant neurobehavioral development. Epigenetics. 2015; 10, 834–841.
25. R Core Team. R: A language and environment for statistical computing. 2013. Retrieved 1 January 2018 from http://www.r-project.org/
27. Deyssenroth, MA, Peng, S, Hao, K, et al. Whole-transcriptome analysis delineates the human placenta gene network and its associations with fetal growth. BMC Genomics. 2017; 18, 520.
28. Rasouli, H, Hosseini-Ghazvini, SM, Adibi, H, Khodarahmi, R. Differential alpha-amylase/alpha-glucosidase inhibitory activities of plant-derived phenolic compounds: a virtual screening perspective for the treatment of obesity and diabetes. Food Funct. 2017; 8, 1942–1954.
29. Zerenturk, EJ, Sharpe, LJ, Ikonen, E, Brown, AJ. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis. Progress in Lipid Res. 2013; 52, 666–680.
30. Crespi, B. Genomic imprinting in the development and evolution of psychotic spectrum conditions. Biol Rev Camb Philos Soc. 2008; 83, 441–493.
31. Colland, F, Jacq, X, Trouplin, V, et al. Functional proteomics mapping of a human signaling pathway. Genome Res. 2004; 14, 1324–1332.
32. Probst, OC, Karayel, E, Schida, N, et al. The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells. Biochem J. 2013; 451, 91–99.
33. Wang, CH, Su, PT, Du, XY, et al. Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. J Cell Physiol. 2010; 222, 685–694.
34. Parisi, T, Beck, AR, Rougier, N, et al. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J. 2003; 22, 4794–4803.
35. Wu, L, de Bruin, A, Saavedra, HI, et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature. 2003; 421, 942–947.
36. Ma, S, Chan, YP, Kwan, PS, et al. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Cancer Res. 2011; 71, 583–592.
37. Lieberman, LA, Hunter, CA. Regulatory pathways involved in the infection-induced production of IFN-gamma by NK cells. Microbes Infect. 2002; 4, 1531–1538.
38. Ernst, MC, Issa, M, Goralski, KB, Sinal, CJ. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology. 2010; 151, 1998–2007.
39. Monteiro, P, Feng, G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017; 18, 147–157.
40. Degner, K, Magness, RR, Shah, DM. Establishment of the human uteroplacental circulation: A historical perspective. Reprod Sci. 2017; 24, 753–761.
41. Chiba, S. Molecular mechanism in alpha-glucosidase and glucoamylase. Biosci Biotechnol Biochem. 1997; 61, 1233–1239.
42. Kong, WH, Oh, SH, Ahn, YR, et al. Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models. J Agric Food Chem. 2008; 56, 2613–2619.
43. Liu, Z, Ma, S. Recent advances in synthetic alpha-glucosidase inhibitors. ChemMedChem. 2017; 12, 819–829.
44. Leblond, CS, Nava, C, Polge, A, et al. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet. 2014; 10, e1004580.
45. Sala, C, Vicidomini, C, Bigi, I, Mossa, A, Verpelli, C. Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders. J Neurochem. 2015; 135, 849–858.
46. Han, K, Holder, JL Jr, Schaaf, CP, et al. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature. 2013; 503, 72–77.
47. Moessner, R, Marshall, CR, Sutcliffe, JS, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 2007; 81, 1289–1297.
48. Grissom, NM, Reyes, TM. Gestational overgrowth and undergrowth affect neurodevelopment: similarities and differences from behavior to epigenetics. Int J Dev Neurosci. 2013; 31, 406–414.
49. Pettersson, E, Sjolander, A, Almqvist, C, et al. Birth weight as an independent predictor of ADHD symptoms: a within-twin pair analysis. J Child Psychol Psychiatry. 2015; 56, 453–459.